Creatinine index: a retrospective cohort study in an urban Australian dialysis context

Shaun Chandler1,2, Helen MacLaughlin1,3, Martin Wolley1,2

  • 1Kidney Health Service Royal Brisbane and Women's Hospital, Brisbane, Australia.

Insights

The creatinine index (CI) effectively predicts mortality in Australian haemodialysis patients. A lower CI indicates higher mortality and stroke risk, while a higher CI is linked to better survival and transplant likelihood.

Area of Science:

  • Nephrology
  • Clinical Epidemiology

Background:

  • Maintenance haemodialysis is a catabolic state leading to decreased lean body mass (LBM) and protein energy wasting.
  • Lean body mass (LBM) can be estimated using creatinine kinetic modelling, specifically the creatinine index (CI).
  • Previous studies suggest the CI predicts mortality in haemodialysis patients.

Purpose of the Study:

  • To describe the relationship between the creatinine index (CI) and mortality in an Australian haemodialysis cohort.
  • To assess the CI's utility in identifying patients at risk for mortality and other adverse outcomes.

Main Methods:

  • A cohort of 179 Australian haemodialysis patients from 2015 was followed for 5 years.
  • Creatinine index (CI) was calculated for each patient.
  • Patients were stratified into high and low CI groups based on the median value (18.32 mg/kg/day).
  • Primary outcome was all-cause mortality; secondary outcomes included myocardial infarction, stroke, and transplantation.

Main Results:

  • Patients in the low CI group had significantly higher mortality (76.7%) compared to the high CI group (31.5%) (P < 0.001).
  • The relative risk of mortality was 2.43 times higher in the low CI group versus the high CI group.
  • A lower CI was associated with an increased risk of stroke (RR, 5.43), while a higher CI was associated with a greater likelihood of transplantation (RR, 6.4).

Conclusions:

  • The creatinine index (CI) is strongly associated with mortality and stroke risk in Australian haemodialysis patients.
  • The CI serves as a simple and accurate method to identify patients with low LBM who are at increased risk of morbidity and mortality.
  • This study reinforces the CI's clinical utility in risk stratification for haemodialysis patients.
Abstract

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
47
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
48
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
129
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
63
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
52
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
26